Hillevax, Inc. HLVX 深 滬
等待開盤 08-13 09:30:00 美东时间
2.06
0.000
0.00%
華盛通- 最 高2.08
- 今 開2.08
- 成交量 17.37万股
- 最 低 2.06
- 昨 收 2.06
- 總市值 1.03亿
- 52周最高 2.17
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 1.34
- 委 比 -13.89%
- 總股本 5014.11万
- 歷史最高 24.42
- 量 比 0.12
- 振 幅 0.97%
- 歷史最低 1.34
- 每 手 1
- 風險率 5.99%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多HilleVax Reports Second Quarter 2025 Financial Results
HilleVax, Inc. reported financial results for the second quarter ended June 30, 2025, with cash, cash equivalents, and marketable securities totaling $159.5 million. The company saw decreases in research and development expenses ($3.3 million versus $52.6 million in 2024) and general and administrative expenses ($11.3 million versus $16.6 million in 2024), leading to a reduced net loss of $11.3 million versus $87.5 million in 2024. Additionally, ...
08-06 20:05
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SCS, HNI, LVTX, HLVX on Behalf of Shareholders
NEW YORK, Aug. 4, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or ...
08-05 00:23
HilleVax Announces Merger Agreement with XOMA
An update from HilleVax, Inc ( ($HLVX) ) is now available. On August 4, 2025, H...
08-04 19:48
HilleVax to be acquired by XOMA Royalty
HilleVax (NASDAQ:HLVX) and XOMA Royalty (NASDAQ:XOMA) have entered into a definitive merger agreement, whereby XOMA Royalty will acquire all of the issued and outstanding common shares of HilleVax. ...
08-04 19:16
Xoma Royalty Agrees To Acquire HilleVax $1.95 In Cash Per Share Plus One Non-transferable Contingent Value Right
Under the terms of the Merger Agreement, HilleVax stockholders will receive $1.95 in cash per share of HilleVax common stock at the closing of the merger, plus one non-transferable contingent value right ("CVR"), which
08-04 19:03
HilleVax Enters into a Definitive Agreement to be Acquired by XOMA Royalty for $1.95 in Cash per Share Plus a Contingent Value Right
HilleVax and XOMA Royalty announce a definitive merger agreement, under which XOMA Royalty will acquire all issued and outstanding common shares of HilleVax. HilleVax stockholders will receive $1.95 in cash per share at closing, plus a non-transferable contingent value right (CVR) for potential future payments. The merger is subject to customary closing conditions and is expected to close in September 2025. Key HilleVax stakeholders supporting th...
08-04 11:00
HilleVax Reports Improved Financial Performance
HilleVax, Inc ( ($HLVX) ) has released its Q1 earnings. Here is a breakdown of ...
05-10 12:18
HilleVax Q1 EPS $(0.12) Beats $(0.36) Estimate
HilleVax (NASDAQ:HLVX) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.36) by 66.67 percent. This is a 87.63 percent increase over losses of $(0.97) per share from the same
05-08 19:29
美股大行评级 | 潜在涨幅778.38%！HC Wainwright & Co.上调BioLine Rx目标价至26美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1113752959213998081.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.：维持BioLine Rx(BLRX)"买入"评级，目标价从9美元升至26美元</p> <p>• 德银：上调固特异轮胎橡胶(GT)评级至"买入"，目标价13美元</p> <p
04-01 09:48
HilleVax Reports 2024 Financial Results Amid Strategic Exploration
HilleVax, Inc ( ($HLVX) ) has released its Q4 earnings. Here is a breakdown of ...
03-30 11:50
